Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310602068> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4310602068 endingPage "4361" @default.
- W4310602068 startingPage "4357" @default.
- W4310602068 abstract "To evaluate efficacy of topical interferon alfa-2b (IFN) in the treatment of uveitic macular edema (UME).This is a prospective, interventional case study of patients with UME. Injection IFN was reconstituted into eye drops and a four times/day (QID) application was prescribed. Central macular thickness (CMT) on optical coherence tomography (OCT) scan was evaluated. Improvement in CMT by ≥50 μm from the baseline was studied in eyes with presenting CMT ≥400 μm.Twenty eyes of 20 patients with UME were studied: anterior uveitis (n = 3), anterior + intermediate uveitis (n = 5), posterior uveitis (n = 3), retinal vasculitis (n = 3), and panuveitis (n = 6). Mean CMT at the presentation was 423.3 μm (range: 270-604 μm), which improved at 1 month (n = 16), 2 months (n = 10), and ≥3 months (n = 11) follow-up, to 415.3 μm (range: 247-579 μm) (P = 0.411), 364.4 μm (range: 258-566 μm) (P = 0.099), 344 μm (range: 258-484 μm) (P = 0.001), respectively. Twelve eyes of 12 patients had presenting CMT ≥400 μm. In these cases, decrease in CMT by ≥50 μm was seen in 4/10, 4/5, and 5/6 eyes at 1 and 2 months and ≥3 months follow-up. Mean follow-up was 4 months (range: 1-17 months). Complete resolution of UME was seen only in three eyes. No ocular or systemic side effects were observed.Topical IFN therapy in QID doses is safe but may have limited role in UME. Long-term therapy may improve its efficacy. Larger studies with dose modification, combination with other drugs, and with homogeneous uveitis population are recommended." @default.
- W4310602068 created "2022-12-12" @default.
- W4310602068 creator A5008562162 @default.
- W4310602068 creator A5028038559 @default.
- W4310602068 creator A5071720088 @default.
- W4310602068 creator A5087862400 @default.
- W4310602068 creator A5089397394 @default.
- W4310602068 date "2022-11-30" @default.
- W4310602068 modified "2023-10-17" @default.
- W4310602068 title "Topical interferon therapy in uveitic macular edema" @default.
- W4310602068 cites W1980828833 @default.
- W4310602068 cites W2000471297 @default.
- W4310602068 cites W2075044143 @default.
- W4310602068 cites W2111199877 @default.
- W4310602068 cites W2160063406 @default.
- W4310602068 cites W2424289170 @default.
- W4310602068 cites W2794008467 @default.
- W4310602068 cites W2944231066 @default.
- W4310602068 cites W3169270788 @default.
- W4310602068 cites W3195980075 @default.
- W4310602068 cites W3196678093 @default.
- W4310602068 doi "https://doi.org/10.4103/ijo.ijo_1450_22" @default.
- W4310602068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36453344" @default.
- W4310602068 hasPublicationYear "2022" @default.
- W4310602068 type Work @default.
- W4310602068 citedByCount "2" @default.
- W4310602068 countsByYear W43106020682022 @default.
- W4310602068 countsByYear W43106020682023 @default.
- W4310602068 crossrefType "journal-article" @default.
- W4310602068 hasAuthorship W4310602068A5008562162 @default.
- W4310602068 hasAuthorship W4310602068A5028038559 @default.
- W4310602068 hasAuthorship W4310602068A5071720088 @default.
- W4310602068 hasAuthorship W4310602068A5087862400 @default.
- W4310602068 hasAuthorship W4310602068A5089397394 @default.
- W4310602068 hasBestOaLocation W43106020681 @default.
- W4310602068 hasConcept C118487528 @default.
- W4310602068 hasConcept C141071460 @default.
- W4310602068 hasConcept C2776194053 @default.
- W4310602068 hasConcept C2778257484 @default.
- W4310602068 hasConcept C2779368723 @default.
- W4310602068 hasConcept C2780347916 @default.
- W4310602068 hasConcept C2780886150 @default.
- W4310602068 hasConcept C2992250680 @default.
- W4310602068 hasConcept C71924100 @default.
- W4310602068 hasConceptScore W4310602068C118487528 @default.
- W4310602068 hasConceptScore W4310602068C141071460 @default.
- W4310602068 hasConceptScore W4310602068C2776194053 @default.
- W4310602068 hasConceptScore W4310602068C2778257484 @default.
- W4310602068 hasConceptScore W4310602068C2779368723 @default.
- W4310602068 hasConceptScore W4310602068C2780347916 @default.
- W4310602068 hasConceptScore W4310602068C2780886150 @default.
- W4310602068 hasConceptScore W4310602068C2992250680 @default.
- W4310602068 hasConceptScore W4310602068C71924100 @default.
- W4310602068 hasIssue "12" @default.
- W4310602068 hasLocation W43106020681 @default.
- W4310602068 hasLocation W43106020682 @default.
- W4310602068 hasLocation W43106020683 @default.
- W4310602068 hasLocation W43106020684 @default.
- W4310602068 hasLocation W43106020685 @default.
- W4310602068 hasOpenAccess W4310602068 @default.
- W4310602068 hasPrimaryLocation W43106020681 @default.
- W4310602068 hasRelatedWork W2057053307 @default.
- W4310602068 hasRelatedWork W2085322307 @default.
- W4310602068 hasRelatedWork W2088121996 @default.
- W4310602068 hasRelatedWork W2157112250 @default.
- W4310602068 hasRelatedWork W2467581887 @default.
- W4310602068 hasRelatedWork W2517951456 @default.
- W4310602068 hasRelatedWork W2925314901 @default.
- W4310602068 hasRelatedWork W3008477780 @default.
- W4310602068 hasRelatedWork W3024906342 @default.
- W4310602068 hasRelatedWork W1580939486 @default.
- W4310602068 hasVolume "70" @default.
- W4310602068 isParatext "false" @default.
- W4310602068 isRetracted "false" @default.
- W4310602068 workType "article" @default.